NCRT Combined With Sequential Perioperative PD-1 Inhibitor for LAESCC
ACTIVE_NOT_RECRUITING
Status
Conditions
- Esophageal Squamous Cell Carcinoma (ESCC)
Interventions
- RADIATION: Neoadjuvant Chemoradiotherapy
- DRUG: neoadjuvant immunotherapy
- PROCEDURE: Surgery
- DRUG: adjuvant immunotherapy
Sponsor
RenJi Hospital